Skip to main content
. 2017 Jun 26;30(5):542–549. doi: 10.20524/aog.2017.0170

Table 5.

Patients with contraindications due to drug-drug interactions (DDIs) or potential DDIs to HCV direct-acting antivirals in relation to patient characteristics

graphic file with name AnnGastroenterol-30-542-g006.jpg